Citation Impact
Citing Papers
Correlating the Metabolic Stability of Psychedelic 5-HT2A Agonists with Anecdotal Reports of Human Oral Bioavailability
2014
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
TGF-β: the master regulator of fibrosis
2016 Standout
Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain
2013
Psychedelics
2016 Standout
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
2014
MicroRNA: Biogenesis, Function and Role in Cancer
2010
The neural basis of psychedelic action
2022 Standout
Leukaemogenesis: more than mutant genes
2009
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Downregulation of MicroRNA-30 Facilitates Podocyte Injury and Is Prevented by Glucocorticoids
2013
The role of MicroRNAs in human cancer
2016 Standout
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response
2013
Molecular Mechanisms of RNA Interference
2013 StandoutNobel
Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death
2013
A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
2021
Synthesis and Structure–Activity Relationships ofN-Benzyl Phenethylamines as 5-HT2A/2CAgonists
2014
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
2016 Standout
Works of Muhammad Wasim being referenced
Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36
2013
Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia
2009